Why teams like yours choose Waters
“We processed 10,000+ challenging samples while meeting regulatory demands — day‑in, day‑out.”
— Paul Holme, Synexa Life Sciences
“Recently for [our] oligonucleotide project, we decided to adopt the ACQUITY Premier UPLC System toprevent NSB [non-specific binding]. . . Overall, the performance and quality of Waters new TQ system [Xevo TQ Absolute XR Mass Spectrometer] are widely recognized in the market, and this is precisely why we ultimately chose your solutions."
— Mr. Cheng Lou, Sr. Director, Bioanalysis Department, Medicilon
Purpose-built to work across all modalities
Analyze small molecules, peptides, proteins, and oligonucleotides — without reinventing your methods. As therapeutic modalities become more complex, your lab can gain efficiency and confidence with complete workflows, not workarounds.
Find out how Waters solutions can simplify, standardize, and accelerate your DMPK studies.